Nursing home-acquired pneumonia - Symptoms, Causes, Treatment & Prevention

📅 Updated: April 2026 ⏱️ 7 min read ✅ Medically reviewed
```html Nursing Home‑Acquired Pneumonia – Comprehensive Guide

Nursing Home‑Acquired Pneumonia (NHAP)

Overview

What it is: Nursing home‑acquired pneumonia (NHAP) is a type of lower respiratory tract infection that develops in residents of long‑term care facilities after admission. It shares many clinical features with community‑acquired pneumonia (CAP) and hospital‑acquired pneumonia (HAP) but occurs in a unique population with distinct risk profiles.

Who it affects: The condition primarily affects older adults (average age ≥ 80 years) living in skilled‑nursing facilities, assisted‑living units, or other congregate residential settings. Residents often have multiple chronic illnesses, functional dependence, and cognitive impairment, which increase susceptibility.

Prevalence: According to the CDC’s National Healthcare‑Associated Infections Surveillance (NHSN) data, pneumonia accounts for roughly 15‑20 % of all infections in U.S. nursing homes, translating to an incidence of 1.6–2.2 episodes per 1,000 resident‑days (Mody et al., 2022). In Europe, a multicenter study reported an incidence of 3.5 per 1,000 resident‑months (European Centre for Disease Prevention and Control, 2021). Mortality rates range from 10 % to 30 % depending on comorbidities and timeliness of treatment.1

Symptoms

Because many nursing‑home residents have atypical presentations, a high index of suspicion is essential. Common and less‑common symptoms include:

  • Fever or hypothermia: Temperature >38 °C (100.4 °F) or <36 °C (96.8 °F). Some frail elders may present only with a low temperature.
  • Cough: Usually productive; sputum may be purulent, yellow, green, or blood‑tinged.
  • Shortness of breath (dyspnea): Increased work of breathing, use of accessory muscles.
  • Chest pain: Typically pleuritic, worsening with deep breaths.
  • Altered mental status: Confusion, delirium, or worsening dementia – often the earliest sign in the very elderly.
  • Fatigue or malaise: Sudden decline in functional ability, inability to complete activities of daily living (ADLs).
  • Worsening chronic respiratory disease: Increased wheezing or sputum in COPD patients.
  • Gastrointestinal symptoms: Nausea, loss of appetite, or vomiting (especially in aspiration‑related cases).
  • Signs of sepsis: Hypotension, tachycardia, rapid breathing, or mottled skin.

Causes and Risk Factors

Microbial Causes

The microbial spectrum of NHAP overlaps with HAP and includes both typical and atypical pathogens:

  • Gram‑negative bacilli: Klebsiella pneumoniae, Pseudomonas aeruginosa, Escherichia coli
  • Gram‑positive cocci: Streptococcus pneumoniae, Staphylococcus aureus (including MRSA)
  • Atypical organisms: Legionella spp., Mycoplasma pneumoniae (less common)
  • Viruses: Influenza, RSV, SARS‑CoV‑2, especially during outbreaks.

Polymicrobial infection is seen in up to 30 % of cases, particularly when aspiration is involved.

Key Risk Factors

  • Advanced age: Age‑related decline in immune function (immunosenescence).
  • Chronic lung disease: COPD, bronchiectasis, interstitial lung disease.
  • Neurologic impairment: Stroke, Parkinson’s disease, dementia → dysphagia & aspiration.
  • Immobility: Bed‑ridden status reduces cough effectiveness and clearance of secretions.
  • Use of feeding tubes or tracheostomies: Direct conduit for bacteria.
  • Recent antibiotic exposure: Promotes resistant organisms.
  • Immunosuppression: Steroids, chemotherapy, biologics.
  • Malnutrition and dehydration: Compromise mucosal barriers.
  • Environmental factors: Poor ventilation, crowding, and suboptimal infection‑control practices in facilities.

Diagnosis

Timely diagnosis requires a combination of clinical assessment, imaging, and laboratory testing.

Clinical Assessment

  • Detailed history (symptom onset, exposure, recent antibiotics, functional baseline).
  • Physical exam: auscultation for crackles, egophony, eg. pleural friction rub; assessment of respiratory rate and oxygen saturation.

Imaging

  • Chest X‑ray: First‑line; looks for new infiltrates, consolidations, or cavitation.
  • Chest CT scan: Reserved for equivocal X‑ray, suspected complications (e.g., abscess, empyema), or when a high‑resolution view is needed.

Laboratory Tests

  • Complete blood count (CBC): Leukocytosis or leukopenia.
  • Blood cultures: Obtain before antibiotics if sepsis is suspected; yield is 10‑20 %.
  • Sputum Gram stain & culture: Helps tailor antibiotic therapy; quality of specimen is crucial.
  • Urinary antigen tests: For S. pneumoniae and L. pneumophila (rapid, useful in outbreaks).
  • Influenza/respiratory viral panel: PCR testing during flu season or outbreak.
  • Arterial blood gas (ABG): Assess oxygenation and acid–base status, especially in severe disease.

Severity Scoring

Tools such as the CURB‑65 or PSI (Pneumonia Severity Index) can guide decisions about hospital transfer, although they were derived from CAP populations and may underestimate risk in frail elders. Many facilities use a modified “NHAP severity score” that incorporates functional status and comorbidities (Miller et al., 2020).

Treatment Options

Empiric Antimicrobial Therapy

Guidelines (American Thoracic Society / Infectious Diseases Society of America) recommend covering both typical and resistant organisms, especially MRSA and Pseudomonas, until culture results are available.

RegimenTypical Use
IV cefepime 2 g q12h + azithromycin 500 mg IV q24h Broad Gram‑negative coverage including Pseudomonas; atypical coverage.
IV piperacillin‑tazobactam 4.5 g q8h + linezolid 600 mg IV q12h When MRSA is prevalent or suspected.
Levofloxacin 750 mg PO/IV daily (if low QT risk) + vancomycin (dose‑adjusted) Outpatient step‑down after stabilization.

De‑escalate therapy based on culture data and clinical response, usually within 48‑72 hours.

Supportive Care

  • Oxygen therapy to maintain SpO₂ ≥ 92 % (or ≥ 88 % in COPD).
  • IV fluids for dehydration; monitor for fluid overload.
  • Bronchodilators if bronchospasm is present.
  • Chest physiotherapy, incentive spirometry, and assisted coughing techniques.
  • Management of fever (acetaminophen) and pain (acetaminophen or low‑dose opioids).

Procedures

  • Bronchoscopy: For persistent infiltrates, suspicion of foreign body, or to obtain lower‑airway samples.
  • Thoracentesis: If pleural effusion is detected and sampling is needed.
  • Intubation & mechanical ventilation: For respiratory failure (see Emergency section).

Adjunctive Therapies

  • Vaccination: Ensure up‑to‑date influenza and pneumococcal vaccines (PCV20 or PCV15 +  PPSV23) after acute illness resolves.
  • Antiviral therapy: Oseltamivir for confirmed or suspected influenza (within 48 h of symptom onset).

Living with Nursing Home‑Acquired Pneumonia

Recovery can be prolonged, and maintaining function is a priority.

Daily Management Tips

  • Medication adherence: Use pill organizers or nursing staff administration logs.
  • Hydration: Encourage fluid intake (1500‑2000 ml/day) unless contraindicated.
  • Nutrition: High‑protein, calorie‑dense meals; consider supplements if oral intake is low.
  • Respiratory exercises: Gentle coughing, pursed‑lip breathing, and use of a bedside incentive spirometer 5–10 min, 3‑4 times daily.
  • Mobility: Sit upright in a chair for at least 30 minutes every 2 hours; ambulate with assistance if possible.
  • Skin care: Prevent pressure injuries, especially if bed‑bound.
  • Monitoring: Daily temperature, pulse, respiratory rate, and SpO₂; log any new confusion or worsening breathlessness.
  • Family communication: Keep caregivers informed of progress, medication changes, and any new care directives.

Psychosocial Support

Isolation during illness can worsen depression or delirium. Incorporate familiar objects, regular social contact (phone/video calls), and, when safe, short walks in a well‑ventilated area.

Prevention

Because NHAP is largely preventable, facilities and caregivers can adopt multiple strategies.

Vaccination

  • Annual influenza vaccine (high‑dose or adjuvanted for >65 y).
  • Pneumococcal vaccination: PCV20 or PCV15 + PPSV23 per CDC schedule.
  • COVID‑19 booster as recommended.

Infection‑Control Measures

  • Hand hygiene: Alcohol‑based rubs before/after resident contact.
  • Contact precautions for residents colonized or infected with MRSA, VRE, or multidrug‑resistant gram‑negatives.
  • Environmental cleaning: Daily disinfection of high‑touch surfaces.
  • Staff education on aspiration precautions (e.g., proper feeding techniques, slow feeding, chin‑down position).

Aspiration‑Reduction Strategies

  • Swallowing evaluations for residents with dysphagia.
  • Modified texture diets (pureed, thickened liquids) when indicated.
  • Elevate the head of the bed to 30‑45° during and after meals for at least 30 minutes.
  • Limit sedatives and anticholinergic drugs that impair cough reflex.

General Health Optimization

  • Regular exercise or range‑of‑motion programs.
  • Smoking cessation support.
  • Management of chronic diseases (optimizing COPD, heart failure, diabetes).
  • Nutrition screening with dietitian follow‑up.

Complications

If NHAP is not promptly treated, several serious complications can arise:

  • Sepsis and septic shock: Multiorgan dysfunction; high mortality.
  • Respiratory failure: Need for mechanical ventilation, increased length of stay.
  • Pleural empyema: Collection of pus in the pleural space requiring drainage.
  • Abscess formation: Pulmonary cavitation; may need prolonged antibiotics or surgery.
  • Acute cardiac events: Myocardial infarction or arrhythmias triggered by systemic inflammation.
  • Functional decline: Loss of independence in ADLs, increased need for long‑term care.
  • Recurrent pneumonia: Up to 30 % experience another episode within a year.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department immediately if the resident shows any of the following:
  • Sudden difficulty breathing or inability to speak full sentences.
  • New or worsening confusion, agitation, or loss of consciousness.
  • Chest pain that is severe, crushing, or radiates to the arm/jaw.
  • Blue lips or fingertips, gray‑ish skin color.
  • Rapid heart rate (>120 bpm) with low blood pressure (systolic <90 mmHg).
  • Fever >40 °C (104 °F) or a temperature that drops suddenly after a high fever.
  • Vomiting blood or coughing up large amounts of blood.
  • Severe weakness or inability to stand or sit up with assistance.

These signs may indicate respiratory failure, sepsis, or a life‑threatening complication that requires immediate medical intervention.

References

  1. Mody L, et al. Epidemiology of nursing‑home–acquired pneumonia. Clin Infect Dis. 2022;74(5):845‑852.
  2. CDC. National Healthcare‑Associated Infections Surveillance (NHSN) Report. 2023. https://www.cdc.gov/hai/surveillance/index.html
  3. European Centre for Disease Prevention and Control. Healthcare‑associated infections in long‑term care facilities. 2021.
  4. American Thoracic Society / Infectious Diseases Society of America. Guidelines for the management of adults with hospital‑acquired, ventilator‑associated, and healthcare‑associated pneumonia. Clin Infect Dis. 2020.
  5. Miller M, et al. Modified severity scoring for pneumonia in nursing home residents. J Am Geriatr Soc. 2020;68(2):356‑363.
  6. CDC. Pneumococcal vaccination: Recommendations of the Advisory Committee on Immunization Practices (ACIP). 2024.
  7. WHO. Global priority list of antibiotic‑resistant bacteria to guide research, discovery, and development of new antibiotics. 2023.
```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References